Prognostic value of high-sensitivity C-reactive protein in patients undergoing percutaneous coronary intervention with different glycemic metabolism status
High-sensitivity C-reaction protein (hsCRP), a biomarker of residual inflammatory risk, has been demonstrated with poor cardiovascular outcomes. We aimed to investigate the prognostic value of hsCRP in patient...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Le Li, Shangyu Liu, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao Tags: Research Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Endocrinology | Heart | Percutaneous Coronary Intervention